Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (9): 968-970.DOI: 10.3969/j.issn.1673-8640.2015.09.023
• Orginal Article • Previous Articles
Received:2015-02-28
Online:2015-09-30
Published:2015-09-29
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.09.023
| 组别 | 例数 | Lp-PLA2 (mg/L) | TC (mmol/L) | TG (mmol/L) | HDL-C (mmol/L) | LDL-C (mmol/L) | D-D(ng/mL) |
|---|---|---|---|---|---|---|---|
| 正常对照组 | 62 | 128.78±46.22 | 4.72±0.67 | 1.37±0.78 | 1.34±0.22 | 2.11±0.98 | 455.8(202.3,608.9) |
| ACI组 | 89 | 268.65±89.02 | 4.81±0.78 | 2.02±0.97 | 1.29±0.18 | 3.59±0.79 | 809.7(623.7,946.0) |
| 统计值 | t=11.418 | t=0.743 | t=4.410 | t=1.543 | t=10.32 | Z=-7.676 | |
| P值 | <0.01 | >0.05 | <0.01 | >0.05 | <0.01 | <0.01 |
| 组别 | 例数 | Lp-PLA2 (mg/L) | TC (mmol/L) | TG (mmol/L) | HDL-C (mmol/L) | LDL-C (mmol/L) | D-D(ng/mL) |
|---|---|---|---|---|---|---|---|
| 正常对照组 | 62 | 128.78±46.22 | 4.72±0.67 | 1.37±0.78 | 1.34±0.22 | 2.11±0.98 | 455.8(202.3,608.9) |
| ACI组 | 89 | 268.65±89.02 | 4.81±0.78 | 2.02±0.97 | 1.29±0.18 | 3.59±0.79 | 809.7(623.7,946.0) |
| 统计值 | t=11.418 | t=0.743 | t=4.410 | t=1.543 | t=10.32 | Z=-7.676 | |
| P值 | <0.01 | >0.05 | <0.01 | >0.05 | <0.01 | <0.01 |
| 组别 | 例数 | CIMT(mm) | Lp-PLA2(mg/L) | D-D(ng/mL) |
|---|---|---|---|---|
| 无斑块组 | 18 | 0.89±0.27 | 137.56±55.57 | 465.78±277.62 |
| 稳定斑块组 | 33 | 1.38±0.22* | 198.67±57.25* | 876.24±445.87* |
| 不稳定斑块组 | 38 | 1.41±0.32* | 288.89±79.72*# | 1 011.45±578.52*# |
| 组别 | 例数 | CIMT(mm) | Lp-PLA2(mg/L) | D-D(ng/mL) |
|---|---|---|---|---|
| 无斑块组 | 18 | 0.89±0.27 | 137.56±55.57 | 465.78±277.62 |
| 稳定斑块组 | 33 | 1.38±0.22* | 198.67±57.25* | 876.24±445.87* |
| 不稳定斑块组 | 38 | 1.41±0.32* | 288.89±79.72*# | 1 011.45±578.52*# |
| [1] | 何德化,李卫华. 脂蛋白相关磷脂酶A2与冠心病的相关性研究进展[J]. 心血管病学进展,2008,29(1):57-60. |
| [2] | KOLODGIE FD, BURKE AP, SKORIJA KS, et al.Lipoprotein-associated phosphoipase A2 protein expression in the natural progression of human coronary atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2006,26(11):2523-2529. |
| [3] | 陈峻,马涛,崔天盆. 急性脑梗死患者血浆FDP、D-D和CRP联合检测的临床价值[J]. 标记免疫分析与临床,2013,20(2):111-112. |
| [4] | 中华医学会全国第四届脑血管病学术会议. 各类脑血管疾病诊断要点[J]. 中华神经科杂志,1996,42(6):60-61. |
| [5] | 贵永堃,吕晓红. 脂蛋白相关磷脂酶A2与缺血性脑血管疾病的研究进展[J]. 中风与神经疾病杂志,2011,28(1):86-88. |
| [6] | 龙璐,王钟明,陈贞,等. 急性缺血性脑卒中患者血浆Lp-PLA2水平与颈动脉硬化斑块稳定性及神经功能缺损程度的关系[J]. 检验医学,2013,28(10):885-889. |
| [7] | 叶芸,李苏亮. 脑卒中患者血浆Lp-PLA2水平及临床意义探讨[J]. 检验医学,2014,29(3):249-253. |
| [8] | 陈新民,陈福民.急性缺血性脑卒中患者颈动脉粥样硬化与D-二聚体水平的关系[J].中国医药导刊,2013,15(5):872. |
| [9] | 王慧. 急性脑梗死患者NSE、hs-CRP和D-二聚体检测的临床意义[J]. 中国现代医生,2014,8(21):67-69. |
| [10] | SMITH A,PATTERSON C,YARNELL J,et al.Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study[J]. Circulation,2005,112(20):3080-3087. |
| [11] | VOROBEVA NM,PANCHENKO EP,DOBROVOLSKII AB,et al.Elevated D-dimer in patients with cardiovascular diseases free from thromboembolic complications: what is it associated with and what has to be done[J]. Angiol Sosud Khir,2010,16(4):34-41. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
